<div id="readability-page-1"><p>Swedbank AB lessened its stake in  Align Technology, Inc. (NASDAQ:ALGN - Free Report) by 3.4% in the 3rd quarter, according to the company in its most recent 13F filing with the Securities and Exchange Commission. The fund owned 406,459 shares of the medical equipment provider's stock after selling 14,268 shares during the quarter. Swedbank AB owned approximately 0.56% of Align Technology worth $50,897,000 as of its most recent SEC filing.</p><div><p><span></span><span>Get <strong>Align Technology</strong> alerts:</span></p></div><ul><li>Why These 3 Tech Stocks Could Be the Best Opportunities You're Overlooking</li></ul><p>Other institutional investors have also added to or reduced their stakes in the company. Net Worth Advisory Group acquired a new stake in  Align Technology in the third quarter valued at $245,000.  Exchange Traded Concepts LLC raised its holdings in shares of  Align Technology by 30.9% in the 3rd quarter. Exchange Traded Concepts LLC now owns 5,806 shares of the medical equipment provider's stock valued at $727,000 after purchasing an additional 1,371 shares during the period.  Brighton Jones LLC lifted its stake in  Align Technology by 81.3% in the 3rd quarter. Brighton Jones LLC now owns 2,167 shares of the medical equipment provider's stock valued at $271,000 after purchasing an additional 972 shares during the last quarter.  Bay Harbor Wealth Management LLC grew its holdings in  Align Technology by 59,900.0% during the third quarter. Bay Harbor Wealth Management LLC now owns 600 shares of the medical equipment provider's stock worth $75,000 after purchasing an additional 599 shares during the period.  Finally, Voya Financial Advisors Inc. lifted its position in shares of  Align Technology by 142.4% in the third quarter. Voya Financial Advisors Inc. now owns 2,725 shares of the medical equipment provider's stock valued at $344,000 after buying an additional 1,601 shares during the last quarter. 88.43% of the stock is currently owned by institutional investors and hedge funds. </p><h2>Align Technology Trading Down 0.2%</h2><p>Shares of ALGN opened at $156.45 on Thursday. Align Technology, Inc. has a 12 month low of $122.00 and a 12 month high of $237.23. The firm's 50 day moving average is $145.16 and its 200-day moving average is $153.75. The stock has a market capitalization of $11.22 billion, a PE ratio of 30.32, a P/E/G ratio of 1.91 and a beta of 1.86. </p><ul><li>Buy the Dip? These Earnings Misses Offer Long-Term Upside</li></ul><p>Align Technology (NASDAQ:ALGN - Get Free Report) last issued its quarterly earnings results on Wednesday, October 29th. The medical equipment provider reported $2.61 earnings per share (EPS) for the quarter, beating the consensus estimate of $2.38 by $0.23. Align Technology had a return on equity of 13.96% and a net margin of 9.50%.The business had revenue of $995.69 million during the quarter, compared to analysts' expectations of $980.75 million. During the same period in the previous year, the company posted $2.35 earnings per share. The firm's revenue for the quarter was up 1.8% compared to the same quarter last year.  Equities research analysts predict that  Align Technology, Inc. will post 7.98 earnings per share for the current fiscal year. </p><h2>Analyst Upgrades and Downgrades</h2><p>Several equities research analysts have issued reports on ALGN shares. Piper Sandler  reaffirmed an &#34;overweight&#34; rating and set a $200.00 price target (up previously from $190.00) on shares of Align Technology in a report on Thursday, October 30th. Leerink Partners increased their price objective on shares of Align Technology from $172.00 to $189.00 in a research report on Thursday, October 30th. Barclays started coverage on shares of Align Technology in a research note on Monday, December 8th. They set an &#34;equal weight&#34; rating and a $170.00 target price for the company. Weiss Ratings cut shares of Align Technology from a &#34;hold (c-)&#34; rating to a &#34;sell (d+)&#34; rating in a report on Wednesday, October 8th. Finally, Evercore ISI cut their price objective on shares of Align Technology from $220.00 to $170.00 and set an &#34;outperform&#34; rating for the company in a research report on Tuesday, November 25th. One research analyst  has rated the stock with a Strong Buy rating, six have given a Buy rating, eight have given a Hold rating and one  has assigned  a Sell rating to the company. Based on data from MarketBeat.com, the company currently has a consensus rating of &#34;Hold&#34; and a consensus target price of $172.18.</p><ul><li>MarketBeat Week in Review: 12/25 - 12/29</li></ul><p><b>Get Our Latest Stock Analysis on ALGN</b></p><h2>Align Technology Company Profile</h2> (Free Report)<p>Align Technology, Inc <span>NASDAQ: ALGN<span></span></span> pioneered the use of digital technology in orthodontics through the development of the Invisalign system, a series of clear, removable aligners that provide an alternative to traditional metal braces. Since its founding in 1997 by Zia Chishti and Kelsey Wirth, the Tempe, Arizona–based company has expanded its focus to include intraoral scanners, CAD/CAM software for dental laboratories and comprehensive digital dentistry solutions.  </p><p>The company's signature Invisalign system leverages 3D imaging and computer-aided design (CAD) to create customized aligners that gradually reposition teeth, improving patient comfort and treatment predictability.</p><h2>Featured Articles</h2><ul><li>Five stocks we like better than Align Technology</li><li>Do not delete, read immediately</li><li>INVESTOR ALERT: Tiny “$3 AI Wonder Stock” on the Verge of Blasting Off</li><li>Can Any Expenses Be Deducted From Capital Gains Tax?</li><li>Buffett, Gates and Bezos Quietly Dumping Stocks—Here's Why</li><li>Forget AI, This Will Be the Next Big Tech Breakthrough</li></ul><p><img src="https://imageproxy.pbkrs.com/https://www.marketbeat.com/scripts/SECFilingChart.ashx/query-UHJlZml4PU5BU0RBUSZTeW1ib2w9QUxHTg?x-oss-process=image/auto-orient,1/interlace,1/resize,w_1440,h_1440/quality,q_95/format,jpg" width="650" height="350" original-src="https://imageproxy.pbkrs.com/https://www.marketbeat.com/scripts/SECFilingChart.ashx/query-UHJlZml4PU5BU0RBUSZTeW1ib2w9QUxHTg"/></p><p><em>This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest reporting and unbiased coverage. Please send any questions or comments about this story to contact@marketbeat.com.</em></p><h2>Should You Invest $1,000 in Align Technology Right Now?</h2><p>Before you consider Align Technology, you'll want to hear this.</p><p>MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Align Technology wasn't on the list.</p><p>While Align Technology currently has a Hold rating among analysts, top-rated analysts believe these five stocks are better buys.</p><p>View The Five Stocks Here</p>                  </div>

ALGN

<p>Swedbank AB reduced its stake in Align Technology, Inc. by 3.4% in the third quarter, selling 14,268 shares. The fund now owns 406,459 shares, valued at $50,897,000. Align Technology's recent earnings beat expectations, with a reported EPS of $2.61. Analysts have mixed ratings on the stock, with a consensus rating of 'Hold' and a target price of $172.18.</p>

Swedbank AB Sells 14,268 Shares of Align Technology, Inc. $ALGN